Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Immunoglobulin heavy variable 3-42 (IGHV3-42) is a member of the large family of immunoglobulin heavy chain variable region gene segments that, when functional, encode the variable domain of the heavy chain in immunoglobulins (antibodies)[1][3][5]. However, IGHV3-42 is annotated as a pseudogene[1], meaning that it carries mutations or deletions that prevent it from producing a functional V region in immunoglobulin heavy chains. IGHV genes, in general, contribute to antibody diversity via V(D)J recombination in developing B cells, but pseudogenes like IGHV3-42 are not used in productive antibody rearrangements and do not result in a functional protein product[3][5]. Because IGHV3-42 (pseudogene) does not encode a working protein and is not involved directly in immune response or disease processes, it is not considered a therapeutic target, nor is it a biomarker, nor does it interact with drugs. Note: If a query for IGHV3-42 intended to refer to a specific functional variable gene (rather than a pseudogene), more information would be needed. The available scientific literature and authoritative resources (such as IMGT) treat "IGHV3-42" as a pseudogene and not a functional antibody-encoding gene[1][3]. Key point: IGHV3-42 is a non-functional immunoglobulin variable region pseudogene; it does not encode a functional antibody heavy chain segment and is not a direct therapeutic target[1].
No known mechanism of action due to lack of direct function
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Immunoglobulin heavy variable 3-42 (pseudogene) (IGHV3-42).